Search

Your search keyword '"Hoffmann, Markus"' showing total 935 results

Search Constraints

Start Over You searched for: Author "Hoffmann, Markus" Remove constraint Author: "Hoffmann, Markus" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed Language english Remove constraint Language: english
935 results on '"Hoffmann, Markus"'

Search Results

1. Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens

2. Overcoming leakage in quantum error correction

4. Omicron subvariant BA.5 efficiently infects lung cells

9. Comparison of three indirect methods for verification and validation of reference intervals at eight medical laboratories: a European multicenter study

18. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

19. Safety and Immunogenicity against Ancestral, Delta and Omicron Virus Variants Following a Booster Dose of an Inactivated Whole-Virus COVID-19 Vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial

24. Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations

25. BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19

29. MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination

31. Patients with COVID-19: in the dark-NETs of neutrophils

32. Drugst.One — a plug-and-play solution for online systems medicine and network-based drug repurposing.

33. Diversification of the VH3‐53 immunoglobulin gene segment by somatic hypermutation results in neutralization of SARS‐CoV‐2 virus variants.

34. Molecular Dynamics Study of the Green Solvent Polyethylene Glycol with Water Impurities.

35. Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage.

36. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination

41. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods

43. Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells

44. The Inhibition of Gag-Pol Expression by the Restriction Factor Shiftless Is Dispensable for the Restriction of HIV-1 Infection.

45. Structures and Dynamics of Complex Guest Molecules in Confinement, Revealed by Solid-State NMR, Molecular Dynamics, and Calorimetry.

47. LY6E impairs coronavirus fusion and confers immune control of viral disease

48. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

Catalog

Books, media, physical & digital resources